Ultragenyx
Highly Engaged Employees
Chemicals & Related Products · California, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
60 Leveroni Ct, Novato, California, 9494...Phone Number
(415) 483-8800Website
www.ultragenyx.comRevenue
$730 MillionStock Symbol
RAREIndustry
About Ultragenyx
Ultragenyx is a biopharmaceutical company founded in 2010 that focuses on developing treatments for rare and ultra-rare genetic diseases. The company specializes in creating biologics and small-molecule therapeutics targeting specific genetic disorders with limited treatment options. Ultragenyx's product pipeline includes treatments for metabolic disorders, bone diseases, and enzyme deficiencies. The company operates globally with a strong presence in North America, Europe, and Asia, collaborating with research institutions and pharmaceutical partners to advance its clinical programs. Ultragenyx maintains a commitment to addressing the unmet medical needs of patients with rare genetic conditions through innovative therapeutic approaches.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: RAREShow moreUltragenyx Org Chart
Compare Similar Companies to Ultragenyx
Compare insights from companies similar to Ultragenyx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ultragenyx
$730M
1K - 5K
Public
$1.6B
2010
Howard HornChief Financial Officer & Executive VP, Corporate Strategy
$675.1M
1K - 5K
Private
$225M
2009
LM
Leslie MillingtonSenior Director, Business Strategy & Operations Chief of Staff
Ultragenyx Tech Stack
A closer look at the technologies used by Ultragenyx
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ultragenyx
Sign Up For FreeTo access detailed company insights
Ultragenyx is a biopharmaceutical company founded in 2010 that focuses on developing treatments for rare and ultra-rare genetic diseases. The company specializes in creating biologics and small-molecule therapeutics targeting specific genetic disorders with limited treatment options. Ultragenyx's product pipeline includes treatments for metabolic d... Read More
